Who are in the management team of Lineage Cell Therapeutics, Inc.?

Jun 22 2025 10:06 PM IST
share
Share Via
As of March 2022, the management team of Lineage Cell Therapeutics, Inc. includes Chairman Alfred Kingsley, CEO Brian Culley, and several independent directors: Deborah Andrews, Don Bailey, Neal Bradsher, Stephen Farrell, and Michael Mulroy. This team combines executive leadership with independent governance.
As of March 2022, the management team of Lineage Cell Therapeutics, Inc. includes the following individuals:

- Mr. Alfred Kingsley, Chairman of the Board
- Mr. Brian Culley, Chief Executive Officer, Interim Chief Financial Officer, and Director
- Ms. Deborah Andrews, Independent Director
- Mr. Don Bailey, Independent Director
- Mr. Neal Bradsher, Independent Director
- Mr. Stephen Farrell, Independent Director
- Mr. Michael Mulroy, Independent Director

This team comprises a mix of executive leadership and independent directors contributing to the governance of the company.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Lineage Cell Therapeutics Hits New 52-Week High of $2.09
Nov 04 2025 05:45 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.95
Nov 03 2025 05:00 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.87
Oct 31 2025 04:00 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.85
Oct 15 2025 04:44 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.82
Oct 09 2025 07:58 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.72
Sep 29 2025 02:14 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.64
Sep 24 2025 01:13 PM IST
share
Share Via